CPX -: Adenosine A1 antagonist -: Treatment of cystic fibrosis

被引：2
|
作者：
Sorbera, LA [1 ]
Martín, L [1 ]
Castañer, J [1 ]
机构：
[1] Prous Sci, Barcelona 08080, Spain
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 10期
关键词：
DPCPX;
D O I：
10.1358/dof.2000.025.10.597450
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1011 / 1016
页数：6
相关论文
共 50 条
  • [21] Design, synthesis and biological evaluation of a bivalent μ opiate and adenosine A1 receptor antagonist
    Mathew, Smitha C.
    Ghosh, Nandita
    By, Youlet
    Berthault, Aurelie
    Virolleaud, Marie-Alice
    Carrega, Louis
    Chouraqui, Gaelle
    Commeiras, Laurent
    Condo, Jocelyne
    Attolini, Mireille
    Gaudel-Siri, Anouk
    Ruf, Jean
    Parrain, Jean-Luc
    Rodriguez, Jean
    Guieu, Regis
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6736 - 6739
  • [22] Adenosine A1 receptor antagonist attenuates ischemia-reperfusion injury of the liver
    Magata, S
    Taniguchi, M
    Suzuki, T
    Shimamura, T
    Jin, MB
    Fukai, M
    Yokota, R
    Lida, J
    Horiuchi, H
    Ogata, K
    Kishida, A
    Furukawa, H
    Watanabe, Y
    Nagashima, K
    Todo, S
    TRANSPLANTATION, 1999, 67 (07) : S36 - S36
  • [23] Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist
    He, Wenjie
    Wilder, Tuere
    Cronstein, Bruce N.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (06) : 1167 - 1176
  • [24] LTP induced in the presence of an adenosine A1 antagonist is NMDA receptor-dependent
    de Mendonça, A
    Ribeiro, JA
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 389 - 389
  • [25] New Insight Into A1 Adenosine Receptors in Diabetes Treatment
    Wojcik, Marzena
    Zieleniak, Andrzej
    Wozniak, Lucyna A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (38) : 4237 - 4242
  • [26] Adenosine A1 receptor agonist-antagonist binary compounds. II. Antagonist optimization.
    Lemus, RH
    Matellch, MC
    Reddy, KR
    Wheeler, K
    DaRe, J
    Miller, LP
    Erion, MD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U228 - U228
  • [27] CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity
    Gellai, M
    Schreiner, GF
    Ruffolo, RR
    Fletcher, T
    DeWolf, R
    Brooks, DP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1191 - 1196
  • [28] Pharmacokinetics, Metabolism and Excretion of an Adenosine A1 Receptor Antagonist, Tonapofylline, in Healthy Human Subjects
    Li, Zhaoyang
    Yang, Liyu
    Gan, Liang-Shang
    Klunk, Lewis
    Deykin, Aaron
    Chandra, Prakash
    DRUG METABOLISM REVIEWS, 2010, 42 : 95 - 96
  • [29] Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist
    Nakamura, M
    Nakakimura, K
    Matsumoto, M
    Sakabe, T
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (02): : 161 - 170
  • [30] Industrial synthesis of a novel non-xanthine adenosine A1 receptor antagonist.
    Zanka, A
    Hashimoto, N
    Okamoto, T
    Uematsu, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U358 - U358
12345